Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03166631
Title A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Boehringer Ingelheim
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

BI 754091 + BI 891065

BI 891065

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST